Diuretics for heart failure (Q24203661)

1

0 references

Marcus Flather

2

0 references

Henry Purcell

3

0 references

Andrew JS Coats

Cochrane Database of Systematic Reviews

5

0 references

publication date

15 February 2012

0 references

published in

0 references

cites work

The effects of discontinuing long-term diuretic therapy in the elderly

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Short term effect of withdrawal of diuretic drugs prescribed for ankle oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Withdrawal of long-term diuretic medication in elderly patients: a double blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure--a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Bumetanide in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

The prevalence of left ventricular diastolic filling abnormalities in patients with suspected heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Contracted plasma and blood volume in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Role of mechanical and hormonal factors in cardiac remodeling and the biologic limits of myocardial adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

The underreporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Effect of diuresis on the performance of the failing left ventricle in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

QT dispersion and sudden unexpected death in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

Effect of diuretics on cardiopulmonary performance in severe chronic airflow obstruction. A controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Ibopamine versus hydrochlorothiazide/amiloride in patients with mild congestive heart failure. SK & F Ibopamine Working Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Amiloride improves hemodynamics in patients with chronic congestive heart failure treated with chronic digoxin and diuretics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

The effects of oral ibopamine in patients with mild heart failure--a double blind placebo controlled comparison to furosemide. The Ibopamine Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Deve

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Clinical experience with chlorothiazide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

THE DIURETIC RESPONSE TO FRUSEMIDE

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

[Basic therapy of chronic heart failure with digitalis or diuretics?]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Unnecessary diuretic therapy in the elderly

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Prenalterol as long-term therapy for chronic congestive heart failure. A randomized cross-over trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

A 3-month double-blind cross-over study of the effect of benazepril and hydrochlorothiazide on functional class in symptomatic mild heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Treatment of mild chronic congestive heart failure with ibopamine, hydrochlorothiazide, ibopamine plus hydrochlorothiazide or placebo. A double-blind comparative study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Rationale and design of a randomized trial to assess the effects of diuretics in heart failure: Japanese Multicenter Evaluation of Long- vs Short-Acting Diuretics in Congestive Heart Failure (J-MELODIC)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003838.PUB3

7 January 2021

Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003838.PUB3

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003838.PUB3

Thiazide diuretics, hypokalemia and cardiac arrhythmias.

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003838.PUB3

Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003838.PUB3